A new road to neuroinflammation in Parkinson's disease?

Brain Research Reviews

Volumn 58, Issue 2, 2008, Pages 453-458

  Fuxe, Kjell G ^a   Tarakanov, Alexander O ^b   Goncharova, Larisa B ^c   Agnati, Luigi F ^d,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST PETERSBURG INSTITUTE FOR INFORMATICS AND AUTOMATION   (Russian Federation)

^c City Diagnostic Center Virology   (Russian Federation)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Cytokines; Microglia; Parkinson's disease; Receptor receptor interaction; Substantia nigra

Indexed keywords

ADAPTOR PROTEIN; CHEMOKINE; CYTOKINE; CYTOKINE RECEPTOR; TOLL LIKE RECEPTOR;

CELL MIGRATION; DIMERIZATION; DISEASE ACTIVITY; DOPAMINERGIC NERVE CELL; HUMAN; INNATE IMMUNITY; INTERNALIZATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ANIMALS; HUMANS; NEURONS; PARKINSON DISEASE; RECEPTORS, CYTOKINE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 49449088359     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2008.04.003     Document Type: Review

References (42)

1. Agnati, L.F., Fuxe, K.G., Goncharova, L.B., Tarakanov, A.O., in press. Receptor mosaics of neural and immune communication: possible implications for basal ganglia functions. Brain Res. Rev. doi: 10.1016/j.brainresrev.2007.10.002.
2. Aguirre J.A., Leo G., Cueto R., Andbjer B., Naylor A., Medhurst A.D., Agnati L.F., and Fuxe K. The novel cyclooxygenase-2 inhibitor GW637185X protects against MPTP-toxicity. NeuroReport 19 6 (2008) 657-660
3. Allen S.J., Crown S.E., and Handel T.M. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25 (2007) 787-820
4. Baneres J.L., and Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B-4 receptor BLT1 and the G-protein. J. Mol. Biol. 329 4 (2003) 815-829
5. Bayburt T.H., Leitz A.J., Xie G., Oprian D.D., and Sligar S.G. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J. Biol. Chem. 282 (2007) 14875-14881
6. Bell J.K., Botos I., Hall P.L., Askins J., Shiloaxh J., Segal D.M., and Davies D.R. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. U. S. A. 102 31 (2005) 10976-10980
7. Block M.L., Zecca L., and Hong J.-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev., Neurosci. 8 (2007) 57-59
8. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Revs., Neurosci. 2 (2001) 274-286
9. Cahil C.M., Holdridge S.V., and Morinville A. Trafficking of d-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol. Sci. 28 1 (2006) 23-31
10. Cicchetti F., Brownell A.L., Williams K., Chen Y.I., Livni E., and Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 15 (2002) 991-998
11. Damian M., Martin A., Mesnier D., Pin J.-P., and Bameres J.-L. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J. 25 (2006) 5693-5702
12. Devoino L.V., Alperina E.L., Gevorgyan M.M., and Cheido M.A. Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation. Neurosci. Behav. Physiol. 37 2 (2007) 147-151
13. Fuxe K., Agnati L.F., Benfenati F., Cimino M., Algeri S., Hökfelt T., and Mutt V. Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites. Acta Physiol. Scand. 113 (1981) 567-569
14. Fuxe K., Ferre S., Woods A., Rivera A., Hoistad M., Franco R., Kehr J., and Agnati L.F. Novel strategies for the treatment of Parkinson's disease. Focus on receptor-receptor interactions in the basal ganglia. In: Kehr J., Fuxe K., Ungerstedt U., and Svensson T. (Eds). Monitoring Molecules in Neuroscience (2003), Karolinska University Press, Stockholm, Sweden 199-202
15. Fuxe K., Canals M., Torvinen M., Marcellino D., Terasmaa A., Genedani S., Leo G., Guidolin D., Diaz-Cabiale Z., Rivera A., Lundstrom L., Langel U., Narvaez J., Tanganelli S., Lluis C., Ferre S., Woods A., Franco R., and Agnati L.F. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural. Transm. 114 1 (2007) 49-75
16. Fuxe K., Marcellino D., Genedani S., and Agnati L. Adenosine A2A receptors, dopamine D2 receptors and their interaction in Parkinson's disease. Mov. Disord. 22 14 (2007) 1990-2017
17. Gay N.J., Gangloff M., and Weber A.N.R. Toll-like receptors as molecular switches. Nat. Rev., Immunol. 6 (2006) 693-698
18. Goncharova L.B., and Tarakanov A.O. Molecular networks of brain and immunity. Brain Res. Rev. 55 1 (2007) 155-166
19. Goncharova L.B., and Tarakanov A.O. Nanotubes at neural and immune synapses. Curr. Med. Chem. 15 3 (2008) 210-218
20. Goncharova, L.B., Tarakanov, A.O., in press. Why chemokines are cytokines while their receptors are not cytokine ones? Curr. Med. Chem. 15(13).
21. Guyon A., and Nahon J.-L. Multiple actions of the chemokine stromal cell-derived factor-1a on neuronal activity. J. Mol. Endocrinol. 38 (2007) 365-376
22. Heldin C.H. Dimerization of cell surface receptors in signal transduction. Cell 80 (1995) 213-223
23. Hirono M., Yoshioka T., and Konishi S. GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat. Neurosci. 4 (2001) 1207-1216
24. Matsushima N., Tanaka T., Enkhbayar P., Mikami T., Taga M., Yamada K., and Kuroki Y. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 8 (2007) 124-145
25. Mellado M., Rodriguez-Frade J.M., Vila-Coro A.J., Fernandez S., Martin de Ana A.M., Jones D.R., Toran J.L., and Martinez C. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. Eur. Mol. Biol. Organ. J. 20 (2001) 2497-2507
26. Nikbin N., Edwards C., and Reynolds C. G-protein coupled receptor dimerization. Iranian J. Pharmacol. Ther. 2 1 (2003) 1-11
27. Percherancier Y., Berchiche Y.A., Slight I., Volkmer-Engert R., Tamamura H., Fujii N., Bouvier M., and Heveker N. Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 280 (2005) 9895-9903
28. Pin J.-P., Kniazeff J., Liu J., Binet V., Goudet C., Rondard P., and Prezeau L. Allosteric functioning of dimeric class C G-protein-coupled receptors. FEBS J. 272 (2005) 2947-2955
29. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 3 (2005) 289-298
30. Radons J., Dove S., Neumann D., Altmann R., Botzki A., Martin M., and Falk W. The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain. J. Biol. Chem. 278 49 (2003) 49145-49153
31. Rodriguez-Frade J.M., Mellado M., and Martinez A.C. Chemokine receptor dimerization: two are better than one. Trends Immunol. 22 (2001) 612-617
32. Stomski F.C., Sun Q., Bagley C.J., Woodcock J., Goodall G., Andrews R.K., Berndt M.C., and Lopez A.F. Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding. Mol. Cell. Biol. 16 6 (1996) 3035-3046
33. Toth P.T., Ren D., and Miller R.J. Regulation of CXXR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. J. Pharmacol. Exp. Ther. 310 (2004) 8-17
34. Treanor B., Lanigan P.M.P., Kumar S., Dunsby C., Munro I., Auksorius E., Culley F.J., Purbhoo M.A., Phillips D., Neil M.A.A., Burshtyn D.N., French P.M.W., and Davis D.M. Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses. J. Cell Biol. 174 1 (2006) 153-161
35. Uings I.J., and Farrow S.N. Cell receptors and cell signalling. J. Clin. Pathol.: Mol. Pathol. 53 (2000) 295-299
36. Veldkamp C.T., Peterson F.C., Pelzek A.J., and Volkman B.F. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci. 14 (2005) 1071-1081
37. Vila M., Jackson-Lewis V., Guegan C., Wu D.C., Teismann P., Choi D.K., Tieu K., and Przedborski S. The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14 (2001) 483-489
38. Vila-Coro A.J., Rodriguez-Frade J.M., Martin de Ana A., Moreno-Ortiz M.C., Martinez A.C., and Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13 (1999) 1699-1710
39. Watovich S.S., Wu H., Socolovsky M., Klingmuller U., Constantinescu S.N., and Lodish H.F. Cytokine receptor signal transduction and the control of hematopoietic cell development. Annu. Rev. Cell Dev. Biol. 12 (1996) 91-128
40. White J.F., Grodnitzky J., Louis J.M., Trinh L.B., Shiloach J., Gutierrez J., Northup J.K., and Grisshammer R. Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction. Proc. Natl. Acad. Sci. U. S. A. 104 29 (2007) 12199-12204
41. Whorton M.R., Bokoch M.P., Rasmussen S.G.F., Huang B., Zare R.N., Kobilka B., and Sunahara R.K. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U. S. A. 104 18 (2007) 7682-7687
42. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., James L., Manley J.L., and Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408 (2000) 111-115